Related Experiment Video
Updated: Jul 14, 2026
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
[Paclitaxel-induced lupus]
Alain Lortholary1, Myriam Cary-Ten Have Dallinga, Claude El Kouri
1Service de chimiothérapie, Centre Catherine de Sienne, Nantes. lortholary.alain@catherinedesienne.fr
Introduction:
Paclitaxel (Taxol) is a drug derived from the bark of the Pacific yew tree and is widely used in cancer treatment, especially for breast, ovarian, and lung cancers. It has not previously been reported to induce lupus.
Case:
We report the case of a woman with ovarian cancer who developed paclitaxel-induced lupus on two occasions. Both times, the paclitaxel dramatically improved the ovarian cancer.
Discussion:
The diagnosis of lupus was confirmed by the initial skin appearance, elevated levels of antinuclear antibodies, recurrence on reintroduction, and biopsy results. To our knowledge, it is the first case reported of paclitaxel-induced lupus.